A randomized, double blind, placebo-controlled phase II study of testosterone replacement in men with non-metastatic castrate resistant prostate cancer.
Phase of Trial: Phase II
Latest Information Update: 18 Jul 2014
At a glance
- Drugs Testosterone (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 10 Jun 2014 Status changed from completed to discontinued as reported by ClinicalTrials.gov record.
- 01 Aug 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.